Other NAP books related by word and phrase frequencies

The following titles are likely to be of interest to you. The top keyword and keyphrase weights from this report have been compared with the equivalent lists of words and phrases for all other available NAP publications.

• Safe and Effective Medicines for Children: Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act (2012) (ISBN 0309225493) Marilyn J. Field and Thomas F. Boat, Editors; Committee on Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA); Institute of Medicine


• Medical Devices and the Public's Health: The FDA 510(k) Clearance Process at 35 Years (2011) (ISBN 0309212421) Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process; Institute of Medicine


• The Future of Drug Safety: Promoting and Protecting the Health of the Public (2007) (ISBN 0309103045) Committee on the Assessment of the US Drug Safety System, Alina Baciu, Kathleen Stratton, Sheila P. Burke, Editors


• Public Health Effectiveness of the FDA 510(k) Clearance Process: Measuring Postmarket Performance and Other Select Topics: Workshop Report (2011) (ISBN 0309162068) Theresa Wizemann, Editor; Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process; Institute of Medicine


• Challenges for the FDA: The Future of Drug Safety, Workshop Summary (2007) (ISBN 0309109868) Leslie Pray and Sally Robinson, Rapporteurs, Forum on Drug Discovery, Development, and Translation


• Preventing Medication Errors: Quality Chasm Series (2007) (ISBN 0309101476) Committee on Identifying and Preventing Medication Errors, Philip Aspden, Julie Wolcott, J. Lyle Bootman, Linda R. Cronenwett, Editors


• Rare Diseases and Orphan Products: Accelerating Research and Development (2011) (ISBN 0309158060) Marilyn J. Field and Thomas F. Boat, Editors; Committee on Accelerating Rare Diseases Research and Orphan Product Development; Institute of Medicine


• Public Health Effectiveness of the FDA 510(k) Clearance Process: Balancing Patient Safety and Innovation: Workshop Report (2010) (ISBN 0309158494) Theresa Wizemann, Editor; Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process; Institute of Medicine


• Ethical and Scientific Issues in Studying the Safety of Approved Drugs (2012) (ISBN 0309218136) Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs; Institute of Medicine


• The Ethical Conduct of Clinical Research Involving Children (2004) (ISBN 0309091810) Marilyn J. Field and Richard E. Berman, Editors, Committee on Clinical Research Involving Children


• Addressing the Barriers to Pediatric Drug Development: Workshop Summary (2008) (ISBN 0309107423) Cori Vanchieri, Adrienne Stith Butler, and Andrea Knutsen, Rapporteurs; Forum on Drug Discovery, Development, and Translation; Institute of Medicine


• A Risk-Characterization Framework for Decision-Making at the Food and Drug Administration (2011) (ISBN 0309212804) Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II; National Research Council


• Emergency Care for Children: Growing Pains (2007) (ISBN 0309101719) Committee on the Future of Emergency Care in the United States Health System


• Rational Therapeutics for Infants and Children:Workshop Summary (2000) (ISBN 0309069378) Sumner Yaffe, M.D., Editor; Ronald W. Estabrook, Peter Bouxsein, Sarah Pitluck, Jonathan R. Davis, Roundtable on Research and Development of Drugs, Biologics, and Medical Devices, Division of Health Sciences Policy


• Advancing Regulatory Science for Medical Countermeasure Development: Workshop Summary (2011) (ISBN 0309214904) Theresa Wizemann, Bruce M. Altevogt, and Anne B. Claiborne, Rapporteurs; Forum on Drug Discovery, Development, and Translation; Forum on Medical and Public Health Preparedness for Catastrophic Events; Institute of Medicine